| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |